Loading...
  • encephalopathy
  • 3 - 6 These rates correspond well with reports from other parts of the privileged world, 7 but in the developing world, bilirubin encephalopathy persists as a frequent cause of neonatal morbidity. (aappublications.org)
  • 450 umol/L in the neonatal period and no symptoms or no more than early acute bilirubin encephalopathy develop long term sequelae with impairment of motor development, hearing and executive function compared with a control group. (clinicaltrials.gov)
  • experimental
  • Aetna considers measurement of end-tidal carbon monoxide (CO) corrected for ambient CO (ETCOc), used either alone or in combination with the simultaneous measurement of total serum bilirubin (TSB) concentration, experimental and investigational because measurement of ETCOc has not been proven to improve prediction of development of significant neonatal bilirubinemia over TSB alone. (aetna.com)
  • Clofibrate in combination with phototherapy for neonatal hyperbilirubinemia is considered experimental and investigational. (aetna.com)
  • Intravenous
  • We conclude that oxytocin induction or augmentation of labor does not result in neonatal hemolysis and subsequent hyperbilirubinemia when it is administered without large volumes of sodium-free intravenous solutions. (nih.gov)
  • Guidelines are given for the administration of intravenous immunoglobulin in selected cases of hyperbilirubinaemia due to isoimmunisation. (bmj.com)
  • Procedure
  • The most common encountered complications of ET procedure were hyperglycemia (56.5%), hypocalcaemia (22.5%) and thrombocytopenia (16%) Conclusions: Our data showed that ABO isoimmunization was the most common cause of hyperbilirubinemia. (biomedsearch.com)